Xinhua Medical: The company's products have obtained Class III and Class II medical device registration certificates.

Xinhua Medical Announcement, the company and its wholly-owned subsidiary Shandong Xinhua Blood Technology Co., Ltd. recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the National Medical Products Administration and the Shandong Provincial Medical Products Administration. Among them, the blood dialyzer is suitable for blood dialysis treatment of acute and chronic renal failure patients, with approval date of December 23, 2025, and validity period until December 22, 2030. The parathyroid hormone assay kit and the serum amyloid A/C-reactive protein dual assay kit have also obtained the corresponding registration certificates.